Microneedling in Combination with Topical Pimecrolimus 1% versus Topical Pimecrolimus 1% for the Treatment of Refractory Stable Vitiligo: A Randomized Clinical Trial

CONCLUSION: This study established that combination therapy results in more significant patient improvement. Additionally, one patient experienced mild skin irritation as a side effect of topical pimecrolimus.PMID:34887918 | PMC:PMC8651420 | DOI:10.1155/2021/5652140

Source: Dermatology Research and Practice - December 10, 2021 Category: Dermatology Authors: Fariba Iraji Ali Asilian Zahra Talebzadeh Mina Saber Fatemeh Mokhtari Amirhossein Siadat Seyed Mohsen Hosseini Source Type: research